Manufacturers and importers of knee implants directed to furnish pricing data on orthopedic knee implants (for knee replacement system) by 12th August, 2021 in format prescribed by the pricing authority by Lexplosion | Aug 9, 2021 | Central, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
CDSCO proposes the Draft New Drugs and Clinical Trials (Amendment) Rules, 2021; invites objections/suggestions by 14th September, 2021 by Lexplosion | Aug 5, 2021 | Central, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
Department of Commerce restricts the export of Remdesivir Injection & Remdesivir Active Pharmaceutical Ingredients (API) ; no separate export authorization will be required by Lexplosion Solution | Jun 17, 2021 | Central, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
Govt. prohibits the export of injection Remdesivir and Remdesivir API with immediate effect; all domestic manufacturers of Remdesivir directed to display details of their stockists / distributors on their websites by Lexplosion | Apr 13, 2021 | Central, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
Govt. notifies the Production Linked Incentive Scheme for Pharmaceuticals ; states the eligibility & Approval and Disbursement Process under the Scheme by Lexplosion | Mar 8, 2021 | Central, OPS, PharmaceuticalsThe Ministry of Chemicals and Fertilizers (“Ministry”) has, through a Gazette Notification dated... Read More
